Trial intelligence / Profile preview

Effect of codeine on pharyngeal and esophageal motility in healthy subjects

2017-002349-30Phase 4Completed

Sponsor
Targid
Start
Jun 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of codeine + guaifenesin (2 arms), sponsored by Targid. Primary endpoint: Pharyngeal and esophageal motility patterns. Started Jun 2017; status: completed.

02

Drugs

codeine + guaifenesin

Beyond the preview

Go deeper on 2017-002349-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-002349-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call